Medicine

Hibernation science took advantage of to handle obesity as well as change metabolism

.Attributes Medicine, Posted online: 04 September 2024 doi:10.1038/ s41591-024-03226-wBy recognizing...

CAR- T and also cellular genetics therapies are actually also expensive

.Nature Medicine, Released online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care pr...

The WHO genomics plan of help reasonable implementation of individual genomics for worldwide health

.The publication of the initial draft of the individual genome series in 20011 was actually followed...

A time-stratified, case\u00e2 $ \"crossover research of warm exposure and perinatal mortality from 16 medical facilities in sub-Saharan Africa

.One of 138,015 hospital-based singleton childbirths in 4 sub-Saharan African nations, our team noti...

Advancing worldwide antibiotic investigation, progression and accessibility #.\n\nMurray, C. J. L. et cetera. Global problem of bacterial antimicrobial resistance in 2019: an organized study. Lancet 399, 629\u00e2 $ \"655 (2022 ). AMR Leaders. Towards details devotions and activity in the response to antimicrobial resistance. Global Frontrunners Team on Antimicrobial Resistance https:\/\/www.amrleaders.org\/resources\/m\/item\/glg-report (4 April 2024). Planet Wellness Association. That posts list of micro-organisms for which brand-new prescription antibiotics are actually quickly required. World Health and wellness Organization https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed (27 February 2017). Globe Health Institution. That bacterial concern pathogens listing, 2024: bacterial microorganisms of hygienics relevance to guide investigation, progression as well as methods to stop as well as control antimicrobial resistance. World Health and wellness Company https:\/\/www.who.int\/publications\/i\/item\/9789240093461 (17 May 2024). Silver, L. L. A Gestalt approach to Gram-negative entrance. Bioorg. Med. Chem. 24, 6379\u00e2 $ \"6389 (2016 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nSundqvist, M. Reversibility of antibiotic resistance. Ups. J. Med. Sci. 119, 142\u00e2 $ \"148 (2014 ).\nGoogle Scholar\u00c2.\nGlobe Health And Wellness Company. 2023 antibacterial representatives in professional and also preclinical advancement: an introduction as well as analysis. World Wellness Organization https:\/\/www.who.int\/publications\/i\/item\/9789240094000 (14 June 2024). O' Neill, J. et al. AMR Testimonial. May 19, 2016 \u00e2 $\" Dealing with drug-resistant contaminations around the globe: ultimate record as well as recommendations. Testimonial on Antimicrobial Resistance https:\/\/amr-review.org\/Publications.html (19 May 2016). Drive-AB Range. DRIVE-AB outputs: records as well as briefing. Steer abdominal muscle https:\/\/drive-ab.eu\/drive-ab-outputs\/drive-ab-reports\/ (2016 ). Stern, S. et cetera. Breaking through the wall structure: a call for collective action on antibiotics research and development. Boston ma Consulting Group https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/5_Publikationen\/Gesundheit\/Berichte\/GUARD_Follow_Up_Report_Full_Report_final.pdf (February, 2017). Anderson, M., Panteli, D. &amp Mossialos, E. Plan Quick 51: How can the EU assistance lasting technology as well as accessibility to reliable prescription antibiotics? policy options for existing as well as brand new medications. International Observatory on Health Equipments as well as Plans https:\/\/eurohealthobservatory.who.int\/publications\/i\/how-can-the-eu-support-sustainable-innovation-and-access-to-effective-antibiotics-policy-options-for-existing-and-new-medicines (21 June 2023). Turnidge, J. &amp Christiansen, K. Prescription antibiotic make use of as well as resistance\u00e2 $\" confirming the apparent. Lancet 365, 548\u00e2 $ \"549 (2005 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nPlanet Wellness Institution. 2021 Knowledgeable classification. WHO access, watch, reserve, category of antibiotics for assessment and also monitoring of utilization. Globe Health and wellness Institution https:\/\/www.who.int\/publications\/i\/item\/2021-aware-classification (30 September 2021). European Centre for Illness Protection and also Command. Antimicrobial protection targets: exactly how can our team reach them through 2030? ECDC https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/amr-brief-eaad-2023-update.pdf (2023 ). Planet Wellness Institution. Shortage of technology readied to weaken antibiotic efficiency and health and wellness increases. World Health Company https:\/\/www.who.int\/news\/item\/22-06-2022-22-06-2022-lack-of-innovation-set-to-undermine-antibiotic-performance-and-health-gains (22 June 2022). Magnano San, L. R. et al. Exactly how antimicrobial resistance is linked to temperature modification: an overview of 2 entwined international obstacles. Int. J. Environ. Res. Hygienics 20, 1681 (2023 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nDolecek, C., Shakoor, S., Basnyat, B., Okwor, T. &amp Sartorius, B. Drug-resistant microbial contaminations: our team require important action and investment that pay attention to the weakest hyperlink. PLoS Biol. Twenty, e3001903 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nPlanet Health And Wellness Company. Immunization insurance coverage. Globe Health and wellness Institution https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/immunization-coverage (15 July 2024). Chimhini, G., Magwenzi, M. &amp Fitzgerald, F. C. Infection deterrence and management in low-resource settings: the necessity for the neighborhood, the contextual and the practical. Corrupt. Prev. Pract. 4, 100135 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nNour, S., Stokle, E., Ashiru-Oredope, D. &amp Wesangulae, E. Obstacles of implementing antimicrobial stewardship devices in reduced to mid revenue countries (LMICs). Corrupt. Prev. Pract. 5, 100315 (2023 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nAminov, R. A brief history of the antibiotic time: courses found out and difficulties for the future. Front end. Microbiol. 1, 134 (2010 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nOutterson, K. et cetera. Person get access to in 14 high-income countries to new antibacterials permitted due to the US Fda, European Medicines Agency, Japanese Pharmaceuticals and Medical Instruments Agency, or even Wellness Canada, 2010\u00e2 $ \"2020. Clin. Affect. Dis. 74, 1183\u00e2 $ \"1190 (2022 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nWorld Wellness Organization. 2021 antibacterial brokers in scientific and preclinical growth: a guide and analysis. World Health Association https:\/\/www.who.int\/publications\/i\/item\/9789240047655 (27 May 2022). Antibiotics: the economics must assist the scientific research. Attributes 625, 7 (2024 ). Thomas, D. &amp Wessel, C. The condition of innovation in antibacterial therapies. Biotechnology Development Organization https:\/\/www.bio.org\/sites\/default\/files\/2022-02\/The-State-of-Innovation-in-Antibacterial-Therapeutics.pdf (February, 2022). Strich, J. et al. Assessing specialist utilization of next-generation anti-biotics against resistant Gram-negative diseases in U.S. healthcare facilities: a retrospective pal research study. Ann. Trainee. Med. 177, 559\u00e2 $ \"572 (2024 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nThomas, D. &amp Wessel, C. The state of development in antibacterial therapeutics. Biotechnology Development Institution https:\/\/www.bio.org\/sites\/default\/files\/2022-04\/BIO-Antibacterial-Report-2022.pdf (February 2022). Renwick, M. J., Brogan, D. M. &amp Mossialos, E. A methodical testimonial and also important examination of incentive approaches for exploration and growth of novel prescription antibiotics. J. Antibiot. 69, 73\u00e2 $ \"88 (2016 ). Article\u00c2.\nCAS\u00c2.\n\nGoogle.com Scholar\u00c2.\nHealth Urgent Readiness and Reaction Authorization. R &amp d of health care countermeasures. European Percentage https:\/\/health.ec.europa.eu\/health-emergency-preparedness-and-response-hera\/preparedness\/research-and-development-medical-countermeasures_en (2024 ). European Compensation. Pre-draft proposition for an European alliance under Perspective Europe One Health Antimicrobial Protection. International Compensation https:\/\/research-and-innovation.ec.europa.eu\/system\/files\/2022-02\/ec_rtd_he-partnerships-onehealth-amr.pdf (9 February 2022). Global Prescription Antibiotic Trial And Error Partnership. Entasis Therapies and the Worldwide Anti-biotic Study &amp Development Partnership to build a new therapy for gonorrhea. GARDP https:\/\/gardp.org\/entasis-therapeutics-and-the-global-antibiotic-research-development-partnership-to-develop-a-new-treatment-for-gonorrhea\/ (6 July 2017). Atal, I., Trinquart, L., Porcher, R. &amp Ravaud, P. Differential globalization of business- and also non-industry-sponsored medical tests. PLoS ONE 10, e0145122 (2015 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nWorld Wellness Organization. Amount of medical trial registrations by area, ailment, stage of growth, age and sexual activity of trial individuals (1999\u00e2 $ \"2022). Planet Health and wellness Organization https:\/\/www.who.int\/observatories\/global-observatory-on-health-research-and-development\/monitoring\/number-of-trial-registrations-by-year-location-disease-and-phase-of-development (February 2023). Global Anti-biotic Research and Development Alliance. NeoSept1: a research to figure out the rank of existing and also brand new prescription antibiotics blends to handle newborns who are in medical facility along with serious sepsis. ISRCTN computer registry https:\/\/www.isrctn.com\/ISRCTN48721236 (17 January 2022). Public Health Organization of Canada. Authorities of Canada makes significant financial investment to eliminate antimicrobial protection (AMR), Government of Canada https:\/\/www.canada.ca\/en\/public-health\/news\/2023\/05\/government-of-canada-makes-important-investment-to-fight-antimicrobial-resistance-amr.html (11 May 2023). International Anti-biotic Trial And Error Relationship. Asia authorities funding sustains GARDP\u00e2 $ s attempts to resist antibiotic protection. GARDP https:\/\/gardp.org\/japan-government-funding-supports-gardps-efforts-to-counter-antibiotic-resistance\/ (19 October 2023). Novo Nordisk Groundwork. Novo Nordisk Groundwork companions along with CARB-X to combat drug-resistant infections. novo nordisk base https:\/\/novonordiskfonden.dk\/en\/news\/novo-nordisk-foundation-partners-with-carb-x-to-fight-drug-resistant-infections\/ (9 January 2024). International Commission: European Health as well as Digital Manager Agency. Research on carrying AMR health care countermeasures to the market place. Publications Workplace of the European Union https:\/\/op.europa.eu\/en\/publication-detail\/-\/publication\/51b2c82c-c21b-11ed-8912-01aa75ed71a1\/language-en (2023 ). Outterson, K. Predicting the appropriate dimension of international pull incentives for anti-bacterial medicines. Health and wellness Aff. 40, 1758\u00e2 $ \"1765 (2021 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nEvans, E. J., Meyer, A. &amp Conti, R. M. Sizing a market entry perks for the advancement of brand-new prescription antibiotics. Harvard Kennedy Institution https:\/\/www.hks.harvard.edu\/sites\/default\/files\/centers\/mrcbg\/Final_AWP_232.pdf (May 2024). Morel, C. M. et cetera. Market rewards and also antibiotic resistance: an introduction to the antibiotic sensitivity bonus offer. J. Antibiot. 73, 421\u00e2 $ \"428 (2020 ). CAS\u00c2.\n\nGoogle.com Scholar\u00c2.\nBonnifield, R. &amp Towse, A. A determined USG progressed devotion for subscription-based acquiring of unique antimicrobials and also its own assumed roi. Facility for Global Advancement https:\/\/www.cgdev.org\/publication\/ambitious-usg-advanced-commitment-subscription-based-purchasing-novel-antimicrobials (15 Nov 2022). Towse, A. &amp Silverman Bonnifield, R. G7 investments in new anti-biotics would certainly pay \u00e2 $\" for everyone. Workplace of Health Economics https:\/\/www.ohe.org\/insight\/g7-investments-in-new-antibiotics-would-pay-off-for-everyone\/ (9 December 2022). NHS England. NHS boosts fight versus dangerous infections adhering to prosperous world-first captain. NHS England https:\/\/www.england.nhs.uk\/2023\/07\/nhs-steps-up-battle-against-life-threatening-infections-following-successful-world-first-pilot\/ (11 July 2023). US Our lawmakers. S. 1355 \u00e2 $\" PASTEUR Act of 2023. congress.gov www.congress.gov\/bill\/118th-congress\/senate-bill\/1355#:~:text=This%20bill%20authorizes%20the%20Department,and%20contains%20other%20related%20provisions (27 April 2023). International Commission. Reform of the EU pharmaceutical legalisation. European Commission https:\/\/health.ec.europa.eu\/medicinal-products\/pharmaceutical-strategy-europe\/reform-eu-pharmaceutical-legislation_en (26 April 2023). Gotham, D. et cetera. Repayment styles to confront market failures for antimicrobials: strategies consumed France, Germany, Sweden, the UK, and also the United States. Health Plan 125, 296\u00e2 $ \"306 (2020 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nInternational Federation of Drug Manufacturers as well as Organizations. From protection to resilience: what could the potential antibiotic pipe seem like? IFMPA https:\/\/www.ifpma.org\/publications\/from-resistance-to-resilience-what-could-the-future-antibiotic-pipeline-look-like\/ (14 May 2024). Global AMR R&ampD Hub &amp Globe Wellness Organization. Incentivising the progression of brand new anti-bacterial procedures: 2023 report card due to the Global AMR R&ampD Center and also That. International AMR R&ampD Hub https:\/\/globalamrhub.org\/publications\/incentivising-the-development-of-new-antibacterial-treatments-2023\/ (2023 ). Glover, R. E., Vocalist, A., Roberts, A. P. &amp Kirchhelle, C. Why is the UK registration version for prescription antibiotics taken into consideration effective? Lancet Microorganism 4, e852\u00e2 $ \"e853 (2023 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nNon-paper \u00e2 $\" unique stimuli for the development and also going on the market of antimicrobials. Politician https:\/\/www.politico.eu\/wp-content\/uploads\/2022\/12\/01\/Non-paper-Transferable-exclusivity-voucher-for-AMR-2.pdf (2022 ). Liu, L. et cetera. Global, regional, as well as national root causes of kid death in 2000\u00e2 $ \"thirteen, with projections to update post-2015 concerns: an improved organized evaluation. Lancet 385, 430\u00e2 $ \"440 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nQuadri, F. et cetera. Antibacterial drug deficiencies coming from 2001 to 2013: effects for medical practice. Clin. Corrupt. Dis. 60, 1737\u00e2 $ \"1742 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nBenhabib, A. et cetera. The French coverage unit for drug scarcities: summary and styles from 2012 to 2018: an observational retrospective research. BMJ Open 10, e034033 (2020 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nKlein, E. Y. et al. Assessment of WHO antibiotic intake and also access aim ats in 76 countries, 2000\u00e2 $ \"15: an evaluation of pharmaceutical sales records. Lancet Infect. Dis. 21, 107\u00e2 $ \"115 (2021 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nPyzik, O. Z. &amp Abubakar, I. Fighting the fakes: taking on substandard and falsified medicines. Nat. Rev. Dis. Guides 8, 55 (2022 ). Hayhoe, B., Greenfield, G. &amp Majeed, A. Is it getting less complicated to obtain prescription antibiotics in the UK? Br. J. Gen. Pract. 69, 54\u00e2 $ \"55 (2019 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nBlack Community for Laboratory Medicine. Policy quick and infographics on antimicrobial protection (AMR) in Africa. ASLM https:\/\/aslm.org\/resource\/policy-brief-and-infographics-on-antimicrobial-resistance-amr-in-africa\/ (14 September 2022). Kanu, J. S. et al. National antibiotic consumption for individual make use of in Sierra Leone (2017\u00e2 $ \"2019): a cross-sectional study. Trop. Medication. Affect. Dis. 6, 77 (2021 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nNamugambe, J. S. et al. National antimicrobial consumption: evaluation of core storehouses supplies to in-patient treatment health amenities coming from 2017 to 2019 in Uganda. Trop. Medication. Contaminate. Dis. 6, 83 (2021 ).\nGoogle Scholar\u00c2.\nRobertson, J. et cetera. Variations in the consumption of antimicrobial medicines in the International location, 2014\u00e2 $ \"2018: results and also implications coming from ESAC-Net and also That Europe. Front end. Pharmacol. 12, 639207 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nShukar, S. et cetera. Drug lack: sources, impact, as well as reduction methods. Face. Pharmacol. 12, 693426 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nOutterson, K., Orubu, E. S. F., Rex, J., \u00c3 ... rdal, C. &amp Zaman, M. H. Client accessibility in 14 high-income nations to brand new antibacterials accepted by the US Fda, European Medicines Firm, Japanese Pharmaceuticals and Medical Tools Firm, or Health And Wellness Canada, 2010\u00e2 $ \"2020. Clin. Contaminate. Dis. 74, 1183\u00e2 $ \"1190 (2021 ). Article\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nPulcini, C. et cetera. Wasted anti-biotics: a follow-up inventory research study in Europe, the United States, Canada and also Australia. Int. J. Antimicrob. Agents 49, 98\u00e2 $ \"101 (2017 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nRottingen, J. A. &amp Farrar, J. Targeted wellness technology for international health. Br. Medication. J. 366, 15601 (2019 ).\nGoogle.com Scholar\u00c2.\nAMR Business Partnership. The 2023 AMR Sector Partnership progression poll: production and the setting. amr Market Collaboration https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/12\/AMRIA_Manufacturing-and-the-environment-FINAL.pdf (2023 ). Munoz, V., Visentin, F., Foray, D. &amp Gaule, P. Can medical items be actually cultivated on a charitable manner? Checking out product development relationships for neglected conditions. Sci. Public Policy 42, 315\u00e2 $ \"338 (2015 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nSwaminathan, S. et al. Reboot biomedical R&ampD in the worldwide social rate of interest. Nature 602, 207\u00e2 $ \"210 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nAfrica Centres for Disease Command and Deterrence. Africa CDC pioneers strong transfer to safeguard Africa\u00e2 $ s health and wellness future through developing a 50 billion dollar medical market. AfricaCDC https:\/\/africacdc.org\/news-item\/africa-cdc-spearheads-bold-move-to-secure-africas-health-future-by-creating-a-50-billion-dollar-medical-market\/ (19 February 2024). Gore, C., Morin, S., R\u00c3 \u00b8 ttingen, J. A. &amp Kieny, M. P. Negotiating public-health patent licensing deals to raise accessibility to wellness technologies: an insider\u00e2 $ s account. BMJ Chunk. Health and wellness 8, e012964 (2023 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nSuleman, F., Low, M., Moon, S. &amp Morgan, S. G. New organization designs for research and development with price needs are needed to obtain decent prices of medications. Br. Med. J. 368, l4408 (2020 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nCombating Antibiotic-Resistant Microorganisms Biopharmaceutical Gas. Stewardship as well as gain access to. CARB-X https:\/\/carb-x.org\/about\/stewardship-and-access\/ (2024 ). International Anti-biotic Research and Development Alliance. Shinogi, GARDP and CHAI reveal spots license and collaboration arrangements to manage microbial diseases by broadening accessibility to cefiderocol in 135 countries. GARDP https:\/\/gardp.org\/shionogi-gardp-and-chai-announce-landmark-license-and-collaboration-agreements-to-treat-bacterial-infections-by-expanding-access-to-cefiderocol-in-135-countries\/ (15 June 2022). AMR Industry Collaboration. Leaving behind the laboratory: tracking the downtrend in AMR R&ampD specialists. amr Field Partnership https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/02\/Leaving-the-Lab_final-1.pdf (February, 2024). G7 Wellness Ministers. G7 Health And Wellness Ministers\u00e2 $ Communiqu\u00c3 \u00a9. G7 Germany www.g7germany.de\/resource\/blob\/974430\/2042058\/5651daa321517b089cdccfaffd1e37a1\/2022-05-20-g7-health-ministers-communique-data.pdf (20 May 2022). G20. G20 phone call to action on antimicrobial protection. G7G20 Documents Database https:\/\/g7g20-documents.org\/database\/document\/2022-g20-indonesia-sherpa-track-health-ministers-ministers-annex-g20-call-to-action-on-antimicrobial-resistance (28 October 2022). International Coalition on Aging &amp Contagious Ailments Community of America. 2024 AMR readiness mark progress report. Measuring government activity on AMR policy. Worldwide Coalition on Getting older https:\/\/globalcoalitiononaging.com\/wp-content\/uploads\/2024\/01\/2024-AMR-Index-Progress-Report.pdf (2024 ). Food as well as Farming Association of the United Nations, United Nations Setting Programme, Planet Health And Wellness Organization &amp. Planet Organization for Animal Wellness. International database for tracking antimicrobial resistance (AMR): country self-assessment survey (TrACSS). That https:\/\/amrcountryprogress.org\/

/map-viewindicator2.3 (2023 ). Van Katwyk, S. R. &amp Outterson K. Intro: AMR belongs in the pandemi...

Integrating liver endpoints in scientific tests of heart and also kidney illness

.Attributes Medicine, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Viewpoi...

FALSE:: ERROR: UNSUPPORTED ENCODING...

Artificial knowledge guided assessment for cardiomyopathies in an obstetric population: a practical randomized medical trial

.Test style and oversightThe Screening for PEripartum Cardiomyopathies along with Artificial Intelli...

Sustained HIV remission after allogeneic hematopoietic stem cell transplant along with wild-type CCR5 contributor tissues

.Nature Medication, Published online: 02 September 2024 doi:10.1038/ s41591-024-03277-zHIV remission...

Senolytics target cell senescence-- yet can they reduce aging?

.In the 1960s, United States anatomist Leonard Hayflick noted that replicative cells have a restrict...